v3.26.1
Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Common Stock Equivalents (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]    
Total common stock equivalents excluded from dilutive loss per share 762,457  
Total common stock equivalents included in dilutive income per share   21,801
HBC Earnout Shares [Member]    
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]    
Total common stock equivalents excluded from dilutive loss per share 4,000  
Warrants – Public [Member]    
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]    
Total common stock equivalents excluded from dilutive loss per share 123,500  
Warrants - Private [Member]    
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]    
Total common stock equivalents excluded from dilutive loss per share 108,100  
Warrants - Series A [Member]    
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]    
Total common stock equivalents excluded from dilutive loss per share 508,857  
Stock-based compensation - equity awards [Member]    
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]    
Total common stock equivalents excluded from dilutive loss per share 6,000  
Stock-based compensation - warrants [Member]    
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]    
Total common stock equivalents excluded from dilutive loss per share 12,000  
Stock-based compensation - equity awards [Member]    
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]    
Total common stock equivalents included in dilutive income per share   21,801